Fingerprint
Dive into the research topics of 'A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Joanna Vitfell-Rasmussen, Ian Judson, Akmal Ahmed Safwat, Robin L Jones, Philip Blach Rossen, Maja Lind-Hansen, Poul Knoblauch, Anders Krarup-Hansen